Researchers uncover why typically normal protein drives prostate cancer

NSD-2 is crucial for AR activity in prostate cancer, promoting tumor growth and offering a potential therapeutic target for advanced prostate cancer treatment.

Formycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024 – Biotech Investments

EQS-News: Formycon AG / Key word(s): Conference/Annual Results Formycon invites to the conference call on the results of the financial year 2023 and announces participation

April 23, 2024

Study: E-cigarette use linked to earlier onset of asthma

A significant link between the use of electronic cigarettes and earlier age of asthma onset in U.S. adults was reported by UTHealth Houston researchers May

May 17, 2024

Planet 13 Sells Stock

Planet 13 Announces Pricing of Public Offering of Units LAS VEGAS, March 5, 2024 /PRNewswire/ – Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.